Risk factors for QTc interval prolongation
- 22 November 2017
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 74 (2) , 183-191
Abstract
Prolongation of the QTc interval may result in Torsade de Pointes, a ventricular arrhythmia. Numerous risk factors for QTc interval prolongation have been described, including the use of certain drugs. In clinical practice, there is much debate about the management of the risks involved. In this study, we quantified the effect of these risk factors on the length of the QTc interval.Keywords
This publication has 24 references indexed in Scilit:
- Drug-induced QT interval prolongation: mechanisms and clinical managementTherapeutic Advances in Drug Safety, 2012
- Hypokalemia is associated with lengthening of QT interval in psychiatric patients on admissionPsychiatry Research, 2009
- Accurate electrocardiographic assessment of the QT interval: Teach the tangentHeart Rhythm, 2008
- In‐hospital cardiac arrest is associated with use of non‐antiarrhythmic QTc‐prolonging drugsBritish Journal of Clinical Pharmacology, 2006
- Prolonged QTc Interval and Risk of Sudden Cardiac Death in a Population of Older AdultsJACC, 2006
- Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac deathEuropean Heart Journal, 2005
- Drug-Induced Prolongation of the QT IntervalNew England Journal of Medicine, 2004
- Torsade de Pointes Due to Noncardiac DrugsMedicine, 2003
- Sex, hormones, and repolarizationCardiovascular Research, 2002
- Die Systolendauer im Elektrokardiogramm bei normalen Menschen und bei HerzkrankenActa Medica Scandinavica, 1920